Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006108
Filing Date
2025-05-01
Accepted
2025-05-01 16:19:40
Documents
112
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20250331x10q.htm   iXBRL 10-Q 2515645
2 EX-31.1 bpmc-20250331xex31d1.htm EX-31.1 11232
3 EX-31.2 bpmc-20250331xex31d2.htm EX-31.2 11303
4 EX-32.1 bpmc-20250331xex32d1.htm EX-32.1 10763
  Complete submission text file 0001558370-25-006108.txt   11328682

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpmc-20250331.xsd EX-101.SCH 91672
6 EX-101.CAL bpmc-20250331_cal.xml EX-101.CAL 88236
7 EX-101.DEF bpmc-20250331_def.xml EX-101.DEF 365412
8 EX-101.LAB bpmc-20250331_lab.xml EX-101.LAB 693952
9 EX-101.PRE bpmc-20250331_pre.xml EX-101.PRE 613027
115 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20250331x10q_htm.xml XML 1953170
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 25903417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)